Nav: Home

Investigating what keeps metastatic breast cancer in check

August 27, 2018

At the time of initial diagnosis, most patients with breast cancer show no signs that their cancer has spread elsewhere in the body. Yet, up to 30 percent of patients will ultimately experience metastasis, with breast cancer taking root and growing at other sites in the body, sometimes months, years or even decades later. Sandra McAllister, PhD, of the Division of Hematology at Brigham and Women's Hospital, and her colleagues are working to understand what happens when cancer cells escape from the primary tumor, and what, if anything, can be done to intervene before cancer recurs. In a paper published online in Nature Cell Biology on Aug. 27, McAllister and colleagues reveal an unlikely protector against metastatic growth: inflammation.

"Our findings flip the current thinking on its head," said McAllister, co-senior author of the study. "Many people study primary tumors and the assumption has been that metastases grow the same way. But our work suggests that, while inflammation can help tumor cells escape and land elsewhere in the body, if inflammation is there when they land, it keeps the cells in check. When inflammation is suppressed, the cells grow out."

McAllister and lead author Zafira Castano, PhD, an instructor in the McAllister lab, and colleagues carried out their study in mouse models of metastatic breast cancer and confirmed findings using samples from patients. In the mouse model, the researchers observed that primary tumors triggered an inflammatory reaction that kept tumor cells in the lung from growing. The team reports that levels of interleukin-1β (IL-1β) were especially high in the lungs of mice. When IL-1β was suppressed, the metastases in the lungs grew. When examining samples from patients with breast cancer, the team found that patients who had high levels of IL-1β had lower risk of metastatic tumors.

Inhibitors of IL-1β, such as the drug canakinumab, are currently being tested in clinical trials for the treatment of numerous diseases, including forms of cancer.

"An important implication of our study is that therapies that may prevent the growth of primary tumors may not confer the same beneficial effects for preventing the growth of metastases and further research is required," said McAllister.

While inflammation appeared to prevent the growth of metastatic cancer, it did not appear to kill the cancer cells that had spread zafira.

"This new research has yielded that rare thing: A clue from the cancer itself about how we can fight its spread," said Christine Chaffer of the Garvan Institute for Medical Research, who co-led the study with McAllister. In a separate paper, published recently in Cancer Research, McAllister and colleagues, with lead author Jessalyn Ubellacker, PhD, a former graduate student in the McAllister lab, uncovered a connection between metastasis and a common drug used to treat osteoporosis. In that study, the team found that bisphosphonates could affect bone marrow cells in a way that stopped the growth of breast cancer cells that had spread to the bones. However, they also found evidence that a specific protein - granulocyte-colony stimulating factor (G-CSF) - can help cancer cells overcome this effect. Women with high levels of G-CSF did worse on bisphosphonates than women with low levels of G-CSF.

Both studies may help inform clinical trial design and the selection of patients most likely to benefit from drugs such as IL-1β inhibitors and bisphosphonates.
-end-
Funding for this work was provided by the International Mentoring Foundation for the Advancement of Higher Education; Center for Stem Cell Bioinformatics at the Harvard Stem Cell Institute; Samuel Waxman Cancer Research Foundation, Breast Cancer Research Foundation, and Ludwig Center for Molecular Oncology; Advanced Medical Research Foundation and Nelune Foundation; National Institutes of Health (NCI) RO1 CA166284, Presidential Early Career Award for Scientists and Engineers, American Cancer Society Research Scholar award, and Department of Defense BCMRP Era of Hope Scholar Award W81XWH-14-1-0191.

Paper cited: Castaño, Z et al. "IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization" Nature Cell Biology DOI: 10.1038/s41556-018-0173-5

Brigham and Women's Hospital

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.